Drug Trial Radar · NCT02526160
Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
Last checked: Nov 20, 2026Latest source record: Jun 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
134
Actual
Start
Oct 22, 2015
Primary completion
Dec 22, 2016
Study completion Dec 6, 2018
Sponsor
- Lead sponsor
- Kyowa Kirin, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Kyowa Kirin Co., Ltd.
- First posted
- Aug 18, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary efficacy objective of this study is to establish the effect of burosumab treatment compared with placebo on increasing serum phosphorus levels in adults with XLH.
Conditions
- X-linked Hypophosphatemia
Interventions
burosumabBiological
solution for SC injection
PlaceboOther
saline solution for SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Mean Serum Phosphorus Levels Above the LLN (2.5 mg/dL [0.81 mmol/L]) at the Mid-Point of the Dose Interval, as Averaged Across Dose Cycles Between Baseline and Week 24Time frame: Baseline through Week 24
Locations
25 sites in 7 countries. Site status is shown where the registry gives one.
Children's Hospital of Los Angeles
Los Angeles, California
University of California-San Francisco Medical Center
San Francisco, California
Yale University School of Medicine
New Haven, Connecticut
Indiana University Department of Medicine
Indianapolis, Indiana
Johns Hopkins University
Baltimore, Maryland
Duke University Medical Center
Durham, North Carolina
The Ohio State University Wexner Medical Center
Columbus, Ohio
Houston Methodist Hospital
Houston, Texas
CHU de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction
Le Kremlin-Bicêtre, France
Hôpital Lariboisière, Dept. of Rheumatology
Paris, France
CHU Paris Centre-Hôpital Cochin
Paris, France
St. Vincent's University Hospital
Dublin, Ireland
Azienda Ospedaliero Universitaria Careggi - Neurofarba
Florence, Italy
Okayama Saiseikai General Hospital
Okayama, Japan
Osaka City University Hospital
Osaka, Japan
Osaka University Hospital
Osaka, Japan
Toranomon Hospital
Tokyo, Japan
The University of Tokyo Hospital
Tokyo, Japan
Seoul National University Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
University of Edinburgh Edinburgh Clinical Trials Unit (ECTU) - Western General Hospital
Edinburgh, United Kingdom
Univeristy College of London Hospital
London, United Kingdom
University of Oxford
Oxford, United Kingdom
Northern General Hospital, Metabolic Bone Centre (Sorby Wing)
Sheffield, United Kingdom
Royal National Orthopaedic Hospital
Stanmore, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.